(Q44212684)

30 November 2017

title

Can IL-6 blockade rectify imbalance between Tregs and Th17 cells? (English)

1 reference

30 November 2017

Toshio Tanaka

1

1 reference

30 November 2017

publication date

1 July 2013

1 reference

30 November 2017

1 reference

30 November 2017

volume

5

1 reference

30 November 2017

issue

7

1 reference

30 November 2017

page(s)

695-697

1 reference

The pathogenesis of rheumatoid arthritis

30 November 2017

cites work

1 reference

Therapeutic targeting of the interleukin-6 receptor.

21 January 2018

1 reference

Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases

21 January 2018

1 reference

Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis

21 January 2018

1 reference

IL-6: regulator of Treg/Th17 balance

21 January 2018

1 reference

In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment

21 January 2018

1 reference

Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells

21 January 2018

1 reference

Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy

21 January 2018

1 reference

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.

21 January 2018

1 reference

Interleukin-6: from an inflammatory marker to a target for inflammatory diseases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.13.47

1 reference

30 November 2017

1 reference